fbpx

New Look Reports Record Results for Second Quarter of 2018

New Look Vision Group reported in their latest financial results that revenues reached a record $77.2 million high for the period, an increase of 39.5%.

The revenue increase was mainly due to the previously announced acquisition of Iris, as well as comparable stores sales growth of 2.6% over the same period last year. As a percentage of revenues, adjusted EBITDA in the second quarter increased to 19.8% from 19.7% for the same period last year.

Net earnings attributed to shareholders were $4.0 million, compared to $2.6 million last year, the increase being mainly due to a higher EBITDA, offset by depreciation, financial expenses, and income taxes.

Antoine Amiel, the President and CEO of New Look Vision, stated that: “The record second quarter ended with strong financial and operating results and progress toward our deleveraging goals. While overall results benefited significantly from the Iris acquisition, Q2 is the 16th consecutive quarter of comparable store sales growth. Entering the second half of the year, we maintain our unwavering focus on integration efforts and strengthening our position in the consolidating Canadian retail optical industry.”

When adjusted for acquisition-related costs and other non-comparable costs, Adjusted cash flows from operating activities were $14.6 million, an increase of 35.4% over the same period last year.

Click HERE for the full press release.

Featured Posts

Fighting Blindness Canada

First Patients Dosed in Gene Therapy Trial for USH1B

AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.

Learn More
Voila November-December 2024 Gigi Studios Isotta

GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship

Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.

Read more
Vision Expo new logo

Vision Expo East to Debut New Elevated Experiences and Events in Orlando

Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.

Read more
Transitions Innovation awards 2025- logo

Transitions Optical Announces 2024 Transitions® Innovation Awards Finalists

Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.

Read more
Optical Women’s Association logo

The Optical Women’s Association Announces Global Connection Event at MIDO in Milan

The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.

Read more
Fighting Blindness Canada

First Patients Dosed in Gene Therapy Trial for USH1B

AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.

Learn More
Voila November-December 2024 Gigi Studios Isotta

GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship

Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.

Read More
Vision Expo new logo

Vision Expo East to Debut New Elevated Experiences and Events in Orlando

Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.

Read More
Transitions Innovation awards 2025- logo

Transitions Optical Announces 2024 Transitions® Innovation Awards Finalists

Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.

Read More
Optical Women’s Association logo

The Optical Women’s Association Announces Global Connection Event at MIDO in Milan

The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.

Read More
Fighting Blindness Canada

First Patients Dosed in Gene Therapy Trial for USH1B

AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.

Learn More
Voila November-December 2024 Gigi Studios Isotta

GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship

Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.

Read more
Vision Expo new logo

Vision Expo East to Debut New Elevated Experiences and Events in Orlando

Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.

Read more
Transitions Innovation awards 2025- logo

Transitions Optical Announces 2024 Transitions® Innovation Awards Finalists

Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.

Read more
Optical Women’s Association logo

The Optical Women’s Association Announces Global Connection Event at MIDO in Milan

The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.

Read more
Fighting Blindness Canada

First Patients Dosed in Gene Therapy Trial for USH1B

AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.

Learn More
Voila November-December 2024 Gigi Studios Isotta

GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship

Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.

Read more
Vision Expo new logo

Vision Expo East to Debut New Elevated Experiences and Events in Orlando

Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.

Read more
Transitions Innovation awards 2025- logo

Transitions Optical Announces 2024 Transitions® Innovation Awards Finalists

Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.

Read more
Optical Women’s Association logo

The Optical Women’s Association Announces Global Connection Event at MIDO in Milan

The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.

Read more